⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VOR News
Vor Biopharma Inc. Common Stock
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Form 8-K
sec.gov
VOR
Vor Bio Appoints David Zaccardelli to Board of Directors
globenewswire.com
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Form 8-K
sec.gov
VOR
Form 8-K
sec.gov
VOR
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
globenewswire.com
VOR
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
globenewswire.com
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VOR
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
VOR